Exactech Expands Presence in Japan with Newly Approved Shoulder, Knee and Hip Replacement Systems
June 22 2017 - 9:15AM
Business Wire
Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone
and joint restoration products and biologic solutions for
extremities, knee and hip, announced today that the company marked
the first clinical use of recently approved shoulder, knee and hip
replacement systems in Japan this quarter. These surgeries coincide
with the series of new product introductions the company has
reported in the U.S.
Exactech has gained regulatory approval to introduce additional
products from each of its three major product segments to the
Japanese market. The first Optetrak Logic® CR knee system was
implanted on April 6 at Taketa Medical Association Hospital in
Oita. The Novation® Crown Cup acetabular component debuted on April
26 in Ukubo City. The first Exactech total hip replacement surgery
in Japan took place on May 16 at the Taketa Medical Association
Hospital when a surgeon implanted the Alteon Tapered Wedge Stem
along with the Crown Cup. The first Equinoxe Reverse Shoulder
system was implanted June 5 at Sano Memorial Hospital.
“Exactech has maintained direct distribution in Japan since 2008
with consistent growth. These new product introductions are
important milestones for Exactech in one of our key global
markets,” said Exactech Vice President of International Sales and
Market Development Daniel Berdat. “We are pleased to expand our
offerings with these important innovations to better serve surgeons
and patients.”
About Exactech
Based in Gainesville, Fla., Exactech develops and markets
orthopaedic implant devices, related surgical instruments and
biologic materials and services to hospitals and physicians. The
company manufactures many of its orthopaedic devices at its
Gainesville facility. Exactech’s orthopaedic products are used in
the restoration of bones and joints that have deteriorated as a
result of injury or diseases such as arthritis. Exactech markets
its products in the United States, in addition to more than 30
markets in Europe, Latin America, Asia and the Pacific. Additional
information about Exactech can be found
at http://www.exac.com.
A current investment profile on Exactech (Nasdaq: EXAC) is
available online at http://www.hawkassociates.com/profile/exac.cfm.
To receive future releases in e-mail alerts, sign up at
http://www.hawkassociates.com/about/alert.
This release contains various forward-looking statements within
the meaning of Section 27A of the Securities Act of 1933 and
Section 21E of the Securities Exchange Act of 1934, which represent
the company’s expectations or beliefs concerning future events of
the company’s financial performance. These forward-looking
statements are further qualified by important factors that could
cause actual results to differ materially from those in the
forward-looking statements. These factors include the effect of
competitive pricing, the company’s dependence on the ability of
third party manufacturers to produce components on a basis which is
cost-effective to the company, market acceptance of the company’s
products and the effects of government regulation. Results actually
achieved may differ materially from expected results included in
these statements.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170622005330/en/
Exactech, Inc.Investor contactsJody Phillips,
352-377-1140Executive Vice President of Finance & Chief
Financial OfficerorHawk AssociatesJulie Marshall or Frank Hawkins,
305-451-1888EXAC@hawkassociates.comorExactechMedia
contactsPriscilla Bennett, 352-377-1140Vice President, Corporate
& Marketing Communication
Exactech, Inc. (delisted) (NASDAQ:EXAC)
Historical Stock Chart
From Aug 2024 to Sep 2024
Exactech, Inc. (delisted) (NASDAQ:EXAC)
Historical Stock Chart
From Sep 2023 to Sep 2024